Browse Category

Stock Market News 18 October 2025

NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia’s $4 Trillion AI Frenzy: NVDA Stock Flirts with Record Highs Amid New Risks, Analysts See More Upside

NVDA Stock Rollercoaster Near Record Highs Nvidia’s stock (NASDAQ: NVDA) has been on a wild ride this month. Shares reached an all-time high around $195.62 in early October amid frenzied buying, only to reverse sharply a few days laterts2.tech. By Oct. 14, NVDA plunged over 4% in one session to roughly $180 as traders took profits and a broader tech sell-off hit high-flying namests2.tech. The pullback was short-lived – by the end of the week the stock rebounded to the low-$180s, showing resilience after the mid-week dipts2.tech. Nvidia is still trading near its peak levels, about 58% higher than a
Quantum Stocks (IonQ, Rigetti, D-Wave, Quantum Computing Inc) Surge 700–6,000% – Bubble or Breakthrough? (Oct. 13, 2025)

Rigetti’s Quantum Stock Rollercoaster: RGTI Soars 5,000% Amid Quantum Computing Hype, Then Stumbles – What’s Next?

Stock Soars to Record High, Then Sees Wild Swings Rigetti’s stock price has been on a breathtaking run in 2025, riding a wave of enthusiasm for quantum computing. At the start of the year, RGTI shares traded for under $1. By mid-October, the stock had rocketed into the mid-$50sts2.tech. It closed at a record $56.34 on October 15, 2025ts2.tech – marking an almost 50-fold increase from a year ago. In just the past week, Rigetti exploded from the mid-$40s to new highs, including a ~25% surge in a single day (Oct. 13)ts2.tech. This frenetic rally has lifted Rigetti’s market capitalization
IBM Stock Rockets 28%: AI Boom, Quantum Breakthroughs & Big Deals Spark Rally

IBM Stock Rockets 28%: AI Boom, Quantum Breakthroughs & Big Deals Spark Rally

Recent Stock Rally Driven by AI and Quantum News IBM’s stock has rallied sharply in fall 2025. It closed around $279 on Oct 13 ts2.tech, just shy of its late-September peak near $296 ts2.tech. Investors point to IBM’s pivot to AI, cloud and quantum computing as catalysts. In late September, the company announced a first-of-its-kind quantum computing trial with HSBC, which used IBM’s quantum processor to improve bond-trading forecasts by 34% reuters.com. HSBC’s Philip Intallura said the trial is “a tangible example of how today’s quantum computers could solve a real-world business problem at scale” reuters.com. The news (Sept. 25)
BigBear.ai (BBAI) Stock Rockets 80% in 2025 – Is the Defense-AI Rally Just Beginning?

BigBear.ai’s Stock Skyrockets on Defense AI Deals – Is BBAI the Next Palantir? 🚀

Stock Price Soars Amid Defense AI Boom BigBear.ai’s stock has been on a tear in October as investors pile into defense-focused AI names. On October 13, shares spiked 22% in a single day after the company announced a new AI partnership, leaping from the mid-$7 range to about $8.80ts2.tech. It was BBAI’s biggest one-day jump in over a year. Heavy trading continued as the rally carried into Oct. 14, when the stock hit an intraday high of $9.39stockinvest.us. By mid-week, BBAI hovered near $9 – more than double its value at the start of 2025ts2.tech. However, the ride has been
Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Stock Surge & Analyst Reaction Atai shares exploded higher on Oct. 17, 2025. Investors bid the stock up ~17.7%, closing at roughly $6.45 ts2.tech (versus ~$5.48 offering price). In after-hours trading it briefly touched ~$6.86 ts2.tech. This rally follows a week of good news: BPL-003’s FDA breakthrough, plus well-received capital raise plans. Volume on Oct. 17 was very high (tens of millions of shares), reflecting heavy trading. Over 2025 the stock has skyrocketed ~348% ts2.tech, making ATAI one of the year’s top biotech performers. Its market cap now hovers around $1.2 billion ts2.tech. Analysts have taken notice. Needham Research just initiated
18 October 2025
Cisco Stock Surges Near 52-Week High on AI Momentum – What’s Next for CSCO?

Cisco Stock Surges Near 52-Week High on AI Momentum – What’s Next for CSCO?

CSCO Stock Climbs on Strong Quarter: Cisco’s stock has steadily climbed in 2025, even as many tech peers swung wildly during the AI frenzy. As of mid‑October, CSCO is trading just below its year-high ts2.tech ts2.tech. Over the past week the stock added roughly 2% on investor optimism around recent announcements ts2.tech. Market observers note Cisco’s low volatility (beta <1) and broad support: shares have stayed above key moving averages (50-day ~$68, 200-day ~$65) ts2.tech. “Cisco’s stock has been a steady performer in 2025,” TechStock² (ts2.tech) notes, ~31% higher than a year ago ts2.tech. The company’s market cap is now
New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

Key Stock Metrics: Metric Value (as of Oct 17, 2025) Closing Price $4.55 investing.com 1-Day Change +44.4% (vs $3.15 prev. close) stockanalysis.com Day’s Range $3.20 – $4.71 stockanalysis.com Volume (Oct 17) 33.82 million stockanalysis.com Market Cap ~$129.3 million investing.com 52-Week Range $0.32 – $12.29 stockanalysis.com AI Data Center Pivot Fuels Wild Rally New Era’s stock has rocketed in October thanks to its high-profile push into AI data centers. Mid-September it rebranded from New Era Helium to New Era Energy & Digital, emphasizing its shift into “energy-enabled” digital infrastructure ts2.tech. The company’s 50/50 joint venture, Texas Critical Data Centers (TCDC), is
Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

SPCE’s October Volatility: Surge and Selloff In mid-October 2025, Virgin Galactic’s stock was a top mover in the market. After languishing in the low-$3 range, SPCE shares rallied over 40% in early October on a wave of positive news ts2.tech. For example, on Oct. 16 alone the stock jumped about 6% intraday. Trading volume exploded as speculative traders piled in on hopes of new catalysts ts2.tech reuters.com. However, this enthusiasm was met by profit-taking almost immediately: by Oct. 17 the stock plunged 7.9%, erasing much of the gains and closing around $4.08 ts2.tech reuters.com. The volatile swings were driven by Virgin’s history
18 October 2025
Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Stock Price and Performance As of mid-October 2025, Sellas Life Sciences (NASDAQ:SLS) trades around $2.10–2.20. This is near the top of its 52-week range ($0.77 low) and about twice its price at the start of 2025 stockanalysis.com marketbeat.com. Trading volume and volatility have picked up – for instance, on Oct. 14 a massive spike in call-option activity (761% above average) coincided with bullish sentiment marketbeat.com. The stock’s YTD gain (~100%) far outpaces many small-cap biotechs. Technical platforms note SLS is in “uptrend” territory: the stock is well above its 20-day EMA ($1.89) and 50-day EMA ($1.81) tipranks.com, which TipRanks flags
Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics, a clinical-stage biotech developing the RaniPill® capsule for oral delivery of biologic drugs, was essentially flat around $0.45–$0.50 from mid-September through early October. On Oct. 17, it announced a collaboration with Chugai (which is majority-owned by Roche reuters.com) to turn one of Chugai’s injectable rare-disease antibodies into a pill formulation. The news, coupled with the new funding, ignited a buying frenzy ts2.tech. By mid-day Friday, RANI was up ~180% on the session ts2.tech, markedly outpacing the broader market’s modest gains (the S&P 500 and Nasdaq Composite were each up only ~0.5% that day investing.com). Deal Details: Under the Chugai
18 October 2025
Beyond Meat Stock Implodes: 60% Crash After Shocking Debt-For-Equity Swap

Beyond Meat Stock Implodes: 60% Crash After Shocking Debt-For-Equity Swap

Debt Restructure Sparks Stock Crash Beyond Meat’s brand remains visible to consumers, but behind the scenes its finances are in crisis. In mid-October 2025 the company announced an early settlement of its convertible debt exchange offer, triggering a historic market reaction. As Reuters reports, BYND shareholders are “agonizing” after the company offered existing bondholders new debt and stock in place of their $1.1 billion 2027 notes reuters.com globenewswire.com. With ~96.9% of noteholders participating, Beyond Meat will issue about $196.2 M in new 7.0% convertible notes (due 2030) plus a $12.5 M tender premium – roughly $208.7 M total – and 316.15 million new shares
18 October 2025
Liberty Energy (LBRT) Stock Surges 28% After Q3 Earnings – What’s Next?

Liberty Energy (LBRT) Stock Surges 28% After Q3 Earnings – What’s Next?

Stock Surges on Q3 Results Liberty Energy’s logo (shown above) has been in the spotlight as the stock rallied on the latest earnings. On October 17, one day after Liberty’s Q3 report, the stock soared ~28% intraday, closing at $15.32 (vs. $11.94 the previous day) reuters.com ts2.tech. That move (adding about $3.4 per share of value overnight) came even though broader markets were relatively calm. Traders piled in on the “better-than-feared” outcome. By contrast, LBRT’s shares had been drifting lower for months; at one point earlier in Oct they were down over 40% on the year ts2.tech. Why the sudden
Virgin Galactic Rockets 15% on Space Tourism Buzz – Can SPCE Defy Gravity or Crash Back to Earth?

Virgin Galactic’s Wild October Ride: SPCE Stock Soars on Space Tourism Hype, Then Plummets – What’s Next?

Key Facts – October 18, 2025 SPCE Stock Surge and Pullback After languishing near multi-year lows, Virgin Galactic’s stock staged a sharp rally in the first half of October 2025 – only to whipsaw investors with a sudden reversal. The initial catalyst was a flurry of positive news (detailed below) that sent speculative traders rushing in. SPCE climbed over 40% in two weeks, from about $3.42 on Oct. 1 to $4.89 by Oct. 16ts2.tech. On Oct. 16 alone, the stock jumped ~6%, reflecting renewed optimism. This burst of space-tourism hype lifted SPCE off its recent lows (though it remained well under early
Beyond Meat’s Shocking Collapse: BYND Stock Crashes Below $1 Amid Debt Deal Chaos

Beyond Meat’s Shocking Collapse: BYND Stock Crashes Below $1 Amid Debt Deal Chaos

Key Facts – October 18, 2025 Stock Nosedives into Penny Territory Just a few years ago, Beyond Meat (NASDAQ: BYND) was a Wall Street darling; now it’s a penny stock cautionary tale. The company’s shares cratered below $1 this week after an early debt-restructuring announcement spooked the market. On Monday (Oct. 13), BYND opened around $0.84 – down nearly 60% from its prior close – following news of a drastic debt-for-equity swap ts2.tech. By mid-week, the stock hit record lows in the $0.50–$0.60 range, and it closed Friday at roughly $0.65 Businessinsider. This marks an astonishing fall from its 2019
18 October 2025
New Era Energy & Digital (NUAI) Skyrockets 185% on AI Data Center Buzz – Can the Tiny Stock Sustain the Hype?

New Era Energy & Digital (NUAI) Skyrockets 185% on AI Data Center Buzz – Can the Tiny Stock Sustain the Hype?

Key Facts – October 18, 2025 A Micro-Cap Reinvents Itself for the AI Boom New Era Energy & Digital – until recently known as New Era Helium, Inc. – has radically reinvented its business in 2025. The Midland, Texas-based company pivoted from helium and natural gas exploration toward becoming a developer of “energy-enabled” digital infrastructure for the AI erats2.tech. In August, it officially rebranded to reflect this shift, retaining its gas assets but refocusing on powering data centers. The strategic bet: build a vertically integrated campus where on-site power generation and computing facilities come together to serve the booming demand
ATAI Life Sciences Skyrockets on FDA Breakthrough and $130M Cash Infusion

ATAI Life Sciences Skyrockets on FDA Breakthrough and $130M Cash Infusion

Key Facts – October 18, 2025 Stock Soars on Breakthrough News and Funding Boost ATAI’s stock price surged in the last few days amid a flurry of good news. Shares jumped 17.7% on Friday (Oct 17) alone, finishing at $6.45marketbeat.com, after trading around the mid-$5 range earlier in the week. In fact, as of early Friday, ATAI was already up about 8% for the week on anticipation of the announcementsnasdaq.com. The strong finish came as investors digested multiple catalysts: a coveted FDA designation for a key drug, a fresh capital raise, and bullish commentary from analysts. Notably, after-hours trading on
18 October 2025
MindMed Stock Skyrockets on Psychedelic Breakthroughs – What’s Driving the MNMD Surge?

MindMed Stock Soars 15% to 52-Week High on Psychedelic Breakthrough – What’s Next for MNMD?

Key Facts – October 18, 2025 MNMD Stock Rallies to New Highs on Heavy Volume MindMed’s stock has been on fire, vastly outperforming the broader market in recent weeks. Shares rocketed to a 52-week high of $13.09 on October 14, closing that day at $12.58 on unusually heavy volumets2.tech. After a brief mid-week pullback on profit-taking (shares dipped ~4% intraday on Oct. 16)ts2.tech, MNMD roared back by week’s end – closing at $13.65 on Friday, Oct. 17, a one-day gain of +14.6%investing.com. This rally has propelled MindMed to roughly +68% YTD returnsts2.tech, a remarkable run fueled by excitement over the
18 October 2025
Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences Stock Soars on Patent Win and HIV Breakthroughs – Will the Rally Continue?

Key Facts – October 18, 2025 GILD Stock Price Rallies to New Heights Gilead’s stock has been on a tear in recent weeks, far outpacing the broader market. After trading in the high $110s earlier in October, GILD spiked 4.2% on Friday, Oct. 17, to close at $122.81stockanalysis.comstockanalysis.com. That rally marked a new 2025 high for the biotech stalwart and brings its year-to-date gain to roughly 45–47%ts2.tech. By comparison, the Nasdaq Biotechnology Index is up only in the single digits over the same periodts2.tech. The recent jump – adding billions to Gilead’s market cap – reflects mounting investor enthusiasm driven
Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Liberty Energy (LBRT) Stock Soars 28% on Earnings Surprise – Can the Rally Last?

Key Facts – October 18, 2025 Stock Skyrockets on Earnings News Liberty Energy’s latest earnings release sparked a stunning rally in its stock. On October 17, the day after results, LBRT jumped over 20% intraday, hitting the mid-$15 rangets2.tech. It ultimately closed at $15.32 on Friday (Oct 17), up 28.3% in one dayreuters.com – an eye-catching move on a day when broader markets were relatively quiet. The stock had closed at $11.94 the previous dayreuters.com, so investors added roughly $3.4 per share of value overnight in response to the news. This burst of buying follows a prolonged slump. Liberty’s stock

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop